| 1 |
William H. Geissele |
Whg Properties |
35 |
| 2 |
Scott D. Kuduk |
Merck |
16 |
| 3 |
Sheng-Jiun Wu |
Johnson & Johnson |
3 |
| 3 |
Douglas C. Beshore |
Merck |
3 |
| 3 |
Mark Cunningham |
Johnson & Johnson |
3 |
| #6 |
Joseph H. Gorman, III |
University of Pennsylvania |
2 |
| #6 |
Alexey Teplyakov |
Johnson & Johnson |
2 |
| #6 |
Chichi Huang |
Johnson & Johnson |
2 |
| #6 |
Bernard Scallon |
Johnson & Johnson |
2 |
| #6 |
Xiefan Lin-Schmidt |
Johnson & Johnson |
2 |
| #6 |
Brian Whitaker |
Johnson & Johnson |
2 |
| #6 |
Xuqing Zhang |
Johnson & Johnson |
2 |
| #6 |
Raymond Sweet |
Johnson & Johnson |
2 |
| #6 |
Marian C. Bryan |
Genentech |
2 |
| #6 |
Lani San Mateo |
Johnson & Johnson |
2 |
| #16 |
Kate Sasser |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
1 |
| #16 |
Fang Teng |
Johnson & Johnson |
1 |
| #16 |
Kodandaram Pillarisetti |
Johnson & Johnson |
1 |
| #16 |
Yiqing Feng |
Johnson & Johnson |
1 |
| #16 |
Mary Ryan |
Johnson & Johnson |
1 |
| #16 |
Alfred Del Vecchio |
Viropharma Incorporated |
1 |
| #16 |
Michelle Kinder |
New York University |
1 |
| #16 |
Katharine Heeringa |
Johnson & Johnson |
1 |
| #16 |
Peter T. BUCKLEY |
New York University |
1 |
| #16 |
Keri Dorn |
New York University |
1 |
| #16 |
Rosa Maria Fernandes Cardoso |
Johnson & Johnson |
1 |
| #16 |
Thomas Malia |
Johnson & Johnson |
1 |
| #16 |
Rifat Pamukcu |
Cell Pathways |
1 |
| #16 |
Ken Boakye |
Johnson & Johnson |
1 |
| #16 |
John Kehoe |
Johnson & Johnson |
1 |
| #16 |
Sandra Santulli-Marotto |
Johnson & Johnson |
1 |
| #16 |
Melissa Murdock |
Johnson & Johnson |
1 |
| #16 |
Ravi Malaviya |
Parker Hughes Institute |
1 |
| #16 |
Catherine Healy |
Johnson & Johnson |
1 |
| #16 |
David Shealy |
Johnson & Johnson |
1 |
| #16 |
Eric T. Baldwin |
Elan Pharmaceuticals |
1 |
| #16 |
Anthony Lynch |
New York University |
1 |
| #16 |
Christopher Alderfer |
Johnson & Johnson |
1 |
| #16 |
Francois Gaudet |
Johnson & Johnson |
1 |